KAP vs Psychedelic Harm Reduction & Integration (PHRI)
A side-by-side comparison of recorded mechanisms, evidence review status, related condition topics, and philosophical roots.
At a glance
Source checks, condition-specific assessments and expert review are separate steps. Each assessment applies only to its stated population and use. Topic links do not establish comparative effectiveness.
KAP
- Tradition
- Psychedelic
- Founder
- Various (Wolfson, Bennett) (2010)
- Review status
- 7 source checks available
- Official sources
Guidelines and official sources (7)
6 clinical guideline checks · 1 regulatory source check
Read the recommendation and its scope. A source may discuss an approach without recommending it.
- SPRAVATO (esketamine) original prescribing information
Not a treatment recommendation
The historical drug indication is verified. It does not establish approval or guideline endorsement of KAP. This original label is not current prescribing information.
Scope: Esketamine nasal spray plus an oral antidepressant for adult TRD in 2019
- Management of Major Depressive Disorder
Discussed in the source
VA/DoD weakly suggests ketamine or esketamine augmentation. The recommendation concerns medication, not a named KAP psychotherapy protocol.
Scope: MDD after several adequate pharmacological trials have failed
- Clinical Practice Guideline for Management of PTSD and Acute Stress Disorder
Discussed in the source
VA/DoD weakly recommends against ketamine for PTSD. The statement concerns medication and does not separately evaluate KAP.
Scope: Ketamine pharmacotherapy for adult PTSD; not a separate KAP psychotherapy assessment.
- Assessment and Management of Patients at Risk for Suicide
Discussed in the source
VA/DoD weakly supports ketamine infusion for short-term ideation reduction; evidence for preventing attempts or suicide is insufficient. KAP is not separately recommended.
Scope: Adjunctive ketamine infusion in adults aged 18 and over with major depression and suicidal ideation; medication rather than KAP psychotherapy.
- Management of Major Depressive Disorder
Discussed in the source
VA/DoD suggests against ketamine/esketamine as initial pharmacotherapy (weak against). Its separate augmentation recommendation concerns prior treatment failure; neither recommendation endorses a named KAP psychotherapy protocol.
Scope: Adults choosing initial medication treatment for MDD.
- Management of Bipolar Disorder
Discussed in the source
VA/DoD finds insufficient evidence for ketamine/esketamine alone or as adjuncts. The recommendation concerns medication and does not endorse KAP psychotherapy.
Scope: Adults with acute bipolar depression.
- Clinical Practice Guideline for the Treatment of Posttraumatic Stress Disorder in Adults
Discussed in the source
APA reports insufficient evidence for ketamine in these comparisons. This is a drug-level finding, not a separate evaluation of the KAP psychotherapy protocol.
Scope: Adults with PTSD; ketamine compared with an active or inactive intervention.
- SPRAVATO (esketamine) original prescribing information
- Focus
- Experiential + Processing
- Format
- Individual
- Duration
- Short-medium
Psychedelic Harm Reduction & Integration (PHRI)
- Tradition
- Psychedelic
- Founder
- Various (Gorman, Nielson and colleagues) (2021)
- Review status
- Assessment not yet completed
- Focus
- Integration + Support
- Format
- Individual, group
- Duration
- Variable (brief to ongoing)
How they work
KAP
Core mechanism: Ketamine's dissociative state, and the plasticity that follows it, are treated as a window for psychotherapeutic processing and new learning; the window is proposed rather than demonstrated
Ontology: Treatment-resistant conditions involve rigid neural patterns; ketamine disrupts rigidity and opens plasticity window
Psychedelic Harm Reduction & Integration (PHRI)
Core mechanism: Therapy that begins after the experience is over: the therapist neither supplies nor endorses the substance, and works with whatever the person came back with, whether insight, fear, confusion, or a changed sense of their life
Ontology: Psychedelic experiences can activate deep psychological material that requires skilled therapeutic support to integrate: without integration, the experience remains unmetabolized and potentially destabilizing
Related condition topics
These editorial cross-references organize reading. A shared link does not mean both approaches are effective, recommended, or interchangeable for that condition.
3 shared · 1 KAP-only · 3 Psychedelic Harm Reduction & Integration (PHRI)-only
Linked to both entries
Linked only in the KAP entry
Linked only in the Psychedelic Harm Reduction & Integration (PHRI) entry
What each assumes — and misses
KAP
Philosophical roots: James (varieties of religious experience: altered states as data); Grof (non-ordinary states); Wolfson (ketamine as psychedelic medicine rather than anesthetic adjunct); neuroplasticity research
Blind spots: Regulatory fragmentation; limited standardization of psychotherapy component; risk of ketamine becoming the treatment rather than catalyst
Therapeutic voice: Last week you kept coming back to 'none of it is solid.' Let's stay there. What have you been treating as solid?
Psychedelic Harm Reduction & Integration (PHRI)
Philosophical roots: Zinberg (drug, set, and setting); Grof (non-ordinary states as data); Rogers (unconditional positive regard applied to substance use experiences); harm reduction philosophy (Marlatt); James (varieties of religious experience); contemplative traditions
Blind spots: Minimal controlled research; risk of implicitly endorsing illegal substance use; boundary challenges when clients seek substances through therapist; limited training standards; can attract clinicians with ideological rather than clinical orientation to psychedelics
Therapeutic voice: I'm not here to tell you whether to do it again. I do want to know what you were hoping for, and whether any of it stayed with you.
Choosing between them
KAP and Psychedelic Harm Reduction & Integration (PHRI) both sit within the Psychedelic tradition — they share a worldview about what suffering is and how change happens. Differences are more often about technique and emphasis than about underlying theory.
For deeper coverage: see the full KAP and Psychedelic Harm Reduction & Integration (PHRI) pages, or use the interactive comparison tool to add more modalities to this comparison.